News Search

Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.

Columbia researchers have identified a new gene involved in insulin secretion that could be an attractive target for new diabetes therapies.

Synthetic biologists at Columbia have created a technique that could prevent human-engineered proteins from spreading into the wild or mutating.

CUIMC Celebrates acknowledges individuals at Columbia University Irving Medical Center for their grants, honors, and leadership positions.